{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T10:41:48Z","timestamp":1782038508739,"version":"3.54.5"},"reference-count":35,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IDR"],"DOI":"10.2147\/idr.s395158","type":"journal-article","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:36:15Z","timestamp":1676367375000},"page":"879-889","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of Tigecycline Utilization and Trends in Antibacterial Resistance from 2018 to 2021 in a Comprehensive Teaching Hospital in China"],"prefix":"10.2147","volume":"Volume 16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8183-2391","authenticated-orcid":true,"given":"Hong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaocheng","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoling","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e51034","DOI":"10.15252\/embr.202051034","volume":"21","author":"Huemer","year":"2020","journal-title":"EMBO Rep"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.3390\/ijerph17072337","volume":"17","author":"K\u00f6ck","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1007\/s00018-020-03717-2","volume":"78","author":"Blake","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"ref4","unstructured":"National Health Commission. Notice on continuing to do a good job in clinical application management of antibacterial drugs. National Health Office Medical Letter [2020, No. 8]; 2020. Available from: http:\/\/www.gov.cn\/zhengce\/zhengceku\/2020-07\/24\/content_5529693.htm. Accessed February 7, 2023."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s10096-020-04121-1","volume":"41","author":"Yaghoubi","year":"2022","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1517\/14740338.2015.997206","volume":"14","author":"Kaewpoowat","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"388","DOI":"10.7196\/samj.4109","volume":"100","author":"Brink","year":"2010","journal-title":"S Afr Med J"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"ref9","unstructured":"LiverTox. Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.diagmicrobio.2005.06.001","volume":"52","author":"Hoban","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3389\/fmicb.2018.00549","volume":"9","author":"Zhao","year":"2018","journal-title":"Front Microbiol"},{"key":"ref12","unstructured":"National Health Commission. Notice on Printing and Distributing 3 Technical Documents including Expert Consensus on Clinical Application of Carbapenems Antibacterial Drugs. National Health Office Medical Letter [2018, No. 822]; 2018. Available from: http:\/\/www.nhc.gov.cn\/yzygj\/s7659\/201809\/95f65ca473b44746b24590e94468b8ff.shtml. Accessed February 7, 2023."},{"key":"ref13","unstructured":"China Antimicrobial Resistance Surveillance System. National antimicrobial resistance surveillance report. CARSS; 2020. Available from: http:\/\/www.carss.Cn. Accessed February 7, 2023."},{"key":"ref14","unstructured":"National Health and Family Planning Commission. National action plan for containing bacterial resistance. Available from: http:\/\/www.nhc.gov.cn\/yzygj\/s7659\/201809\/95f65ca473b44746b24590e94468b8ff.shtml. Accessed 31, October 2018."},{"key":"ref15","unstructured":"Guidance for clinical trials of anti-bacterial drugs; 2015. Available from: https:\/\/www.nmpa.gov.cn\/xxgk\/ggtg\/qtggtg\/20150403120001449.html. Accessed February 7, 2023."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1007\/s00134-014-3323-7","volume":"40","author":"Montravers","year":"2014","journal-title":"Intensive Care Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e01511","DOI":"10.1128\/AAC.01511-18","volume":"63","author":"Wang","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3760\/cma.j.issn.1009-9158.2013.07.004","volume":"36","author":"Wang","year":"2013","journal-title":"Chin J Lab Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1186\/s12879-021-06338-7","volume":"21","author":"Babaei","year":"2021","journal-title":"BMC Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3390\/antibiotics11040479","volume":"11","author":"Amann","year":"2022","journal-title":"Antibiotics"},{"key":"ref21","volume-title":"Drugs and Lactation Database (Lactmed) [Internet]","year":"2006"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.2165\/0003495-200868180-00008","volume":"68","author":"McKeage","year":"2008","journal-title":"Drugs"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1159\/000445425","volume":"61","author":"Xu","year":"2016","journal-title":"Chemotherapy"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12941-017-0199-8","volume":"16","author":"Wang","year":"2017","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1086\/431676","volume":"41","author":"Babinchak","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1086\/431675","volume":"41","author":"Ellis-Grosse","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3389\/fmicb.2017.00497","volume":"8","author":"Moghnieh","year":"2017","journal-title":"Front Microbiol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.cmi.2015.11.004","author":"Guan","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3389\/fmed.2022.772372","volume":"39","author":"Liu","year":"2016","journal-title":"Chin Tuber Respir Dis"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1086\/431674","volume":"5","author":"Meagher","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1086\/431674","volume":"10","author":"Liu","year":"2021","journal-title":"Transl Androl Urol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s40265-014-0267-8","volume":"74","author":"Viehman","year":"2014","journal-title":"Drugs"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/1469-0691.12363","volume":"20","author":"Lemos","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"ref35","unstructured":"US FDA. FDA Drug Safety Communication: FDA warns of increased risk of death with IV antibacterial Tygacil (tigecycline) and approves new Boxed Warning; 2013. Available from: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-warns-increased-risk-death-iv-antibacterial-tygacil-tigecycline. Accessed August 3, 2020."}],"container-title":["Infection and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=87499","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=87499","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:36:28Z","timestamp":1676367388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/evaluation-of-tigecycline-utilization-and-trends-in-antibacterial-resi-peer-reviewed-fulltext-article-IDR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":35,"URL":"https:\/\/doi.org\/10.2147\/idr.s395158","relation":{},"ISSN":["1178-6973"],"issn-type":[{"value":"1178-6973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2]]}}}